Day One Biopharmaceuticals (NASDAQ:DAWN – Get Rating) is one of 987 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Day One Biopharmaceuticals to similar businesses based on the strength of its valuation, profitability, institutional ownership, risk, earnings, analyst recommendations and dividends. Insider & […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $14.37, but opened at $14.00. Day One Biopharmaceuticals shares last traded at $14.78, with a volume of 923,241 shares changing hands. Analysts Set New Price Targets A number of brokerages have […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Rating) is one of 958 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its competitors? We will compare Day One Biopharmaceuticals to similar companies based on the strength of its institutional ownership, analyst recommendations, dividends, earnings, risk, profitability and valuation. Institutional and Insider Ownership […]
Day One Biopharmaceuticals (NASDAQ:DAWN – Get Rating) had its price target raised by HC Wainwright from $45.00 to $50.00 in a research report report published on Monday, The Fly reports. HC Wainwright also issued estimates for Day One Biopharmaceuticals’ Q4 2023 earnings at ($0.72) EPS, FY2023 earnings at ($2.65) EPS, FY2024 earnings at ($2.45) EPS, […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Rating) shares fell 5.1% during trading on Thursday . The stock traded as low as $13.60 and last traded at $13.67. 157,126 shares changed hands during trading, a decline of 82% from the average session volume of 886,443 shares. The stock had previously closed at $14.41. Analyst Ratings […]